ロード中...
Tumor control via targeting PD-L1 with chimeric antigen receptor modified NK cells
Failed T cell-based immunotherapies in the presence of genomic alterations in antigen presentations pathways may be overcome by NK cell-based immunotherapy. This approach may still be limited by the presence of immunosuppressive myeloid populations. Here, we demonstrate that NK cells (haNKs) enginee...
保存先:
| 出版年: | eLife |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
eLife Sciences Publications, Ltd
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7340502/ https://ncbi.nlm.nih.gov/pubmed/32633234 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7554/eLife.54854 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|